Background illustration for clinical trials search

Paid Clinical Trials Indiana

Discover 1,127 paid clinical trials in Indiana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Denosumab for Type 1 Diabetes

for
Type 1 Diabetes
Location: Indianapolis IN, Birmingham AL, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18 - 50

Code: NCT06524960

Phase 1, Phase 2, Recruiting

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

for
Sickle Cell Disease
Location: The Bronx NY, Staten Island NY, Baltimore MD,
Sponsor: Sanofi

Sex: All

Age: 10 - 65

Code: NCT06975865

Phase 3, Recruiting

NearWave Optical Molecular Monitoring

for
Breast Cancer, HER2-positive Breast Cancer,
Location: Indianapolis IN
Sponsor: Indiana University

Sex: Female

Age: 18+

Code: NCT06744465

Recruiting

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Sydney, Boston MA, Quebec, Massapequa NY, The Bronx NY,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06283966

Phase 3, Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),
Location: Brewer ME, Gloucester MA, South Weymouth MA, Beverly MA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Rare and Atypical Diabetes Network

for
Diabetes Mellitus, Diabetes Mellitus Progression,
Location: Boston MA, Brooklyn NY, New York NY, Baltimore MD,
Sponsor: University of South Florida

Sex: All

Age: 0+

Code: NCT05544266

Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: New Haven CT, Quebec, New Brunswick NJ, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase 3, Recruiting

Popular cities in Indiana

IndianapolisSouth BendFort WayneEvansville